Can community navigation cut cancer delays? botswana trial aims to find out
NCT ID NCT04141449
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program called Potlako+ that combines community education, support for healthcare providers, and patient navigation to help people with cancer symptoms get diagnosed and treated faster. About 874 participants in Botswana will be split into two groups: one receiving the full Potlako+ program, the other getting standard care. The goal is to see if the program reduces the time from noticing symptoms to starting treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Potlako+ intervention (community education, clinical provider support, patient navigation)
What this could lead to
If successful, this could show that a coordinated community-based program helps catch cancer earlier and get people into treatment faster.
What could go wrong
This is a Phase 2 trial in specific communities in Botswana, so results may not apply elsewhere. The intervention is complex and may not work as hoped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Botswana Harvard AIDS Institute
Gaborone, Botswana